The DOI matches its Crossref record.
Methylmalonic and propionic acidaemias: Management and outcome
Abstract
Summary: Organic acidurias comprise many various disorders. Methylmalonic aciduria (MMA) and propionic aciduria (PA) are the most frequent diseases and the two organic acidurias for which we have better knowledge of the long‐term outcome. Comparing the outcome of patients born before and after 1990, it appears that better neonatal and long‐term management have improved the survival rate. Less than 20% of the patients died in either the neonatal period or before the age of 10 years. However, most surviving patients showed poor nutritional status with growth retardation and about 40% present some kind of visceral or neurological impairment. The developmental outcome may have improved in MMA patients, with IQ higher than 75 in about 40% patients aged more than 4 years. Conversely, poor intellectual development is the rule in PA patterns, with 60% having an IQ less than 75 and requiring special education. Successful liver and/or renal transplantations, in a few patients, have resulted in better quality of life but have not necessarily prevented neurological and various visceral complications. These results emphasize the need for permanent metabolic follow‐up whatever the therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
Baumgartner, M. R., Hörster, F., Dionisi-Vici, C., Haliloglu, G., Karall, D., Chapman, K. A., Huemer, M., Hochuli, M., Assoun, M., Ballhausen, D., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0130-8 · Cited by 705
MACFABE, D., CAIN, D., RODRIGUEZCAPOTE, K., FRANKLIN, A., HOFFMAN, J., BOON, F., TAYLOR, A., KAVALIERS, M., & OSSENKOPP, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.025 · Cited by 497
Forny, P., Hörster, F., Ballhausen, D., Chakrapani, A., Chapman, K. A., Dionisi‐Vici, C., Dixon, M., Grünert, S. C., Grunewald, S., Haliloglu, G., et al. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12370 · Cited by 287
Methylmalonic and propionic aciduria
Deodato, F., Boenzi, S., Santorelli, F. M., & Dionisi‐Vici, C. (2006) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30090 · Cited by 286
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
An, D., Schneller, J. L., Frassetto, A., Liang, S., Zhu, X., Park, J.-S., Theisen, M., Hong, S.-J., Zhou, J., Rajendran, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.081 · Cited by 263
Metadata
- Authors
- De Baulny, H. O., Benoist, J. F., Rigal, O., Touati, G., Rabier, D., & Saudubray, J. M.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 28
- Issue
- 3
- Pages
- 415-423
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1969331640
- Cited by
- 197
- References
- 0
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methylmalonic and propionic acidaemias: Management and outcome. https://app.cochat.ai/papers/10.1007/s10545-005-7056-1
- The paper
- De Baulny, H. O., Benoist, J. F., Rigal, O., Touati, G., Rabier, D., & Saudubray, J. M. (2005). Methylmalonic and propionic acidaemias: Management and outcome. Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-005-7056-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.